Secondary outcomes
Participants are expected to show improvement in emotion regulation (DERS), quality of life (MQLI), positive and negative affect (PANAS), and hopelessness (BHS) at post-treatment (T1) compared to pre-treatment (T0), and this result is expected to remain stable for 3 months (T2). No significant changes in Wait-List Control on these variables are expected at T1 compared to T0.